Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism (TRAIT)

NCT05794165 is registered in ClinicalTrials.gov with Bryan Cotton as lead sponsor.

NCT NCT05794165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05794165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism (TRAIT)
Lead sponsor
Bryan Cotton
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
September 27, 2023
Completion date
September 30, 2027
Enrollment
314 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

thromboembolism, trauma injury, venous thromboembolism